Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma-Reference-Cited by-同舟云学术

Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma

Published:2015-08-20 Issue:8 Volume:126 Page:950-956
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Ceriani Luca¹,Martelli Maurizio²,Zinzani Pier Luigi³,Ferreri Andrés J. M.⁴,Botto Barbara⁵,Stelitano Caterina⁶,Gotti Manuel⁷,Cabras Maria Giuseppina⁸,Rigacci Luigi⁹,Gargantini Livio¹⁰,Merli Francesco¹¹,Pinotti Graziella¹²,Mannina Donato¹³,Luminari Stefano¹⁴^ORCID,Stathis Anastasios¹,Russo Eleonora²,Cavalli Franco¹,Giovanella Luca¹,Johnson Peter W. M.¹⁵,Zucca Emanuele¹

Affiliation:

1. Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;

2. Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy;

3. Institute of Hematology and Medical Oncology, Policlinico S. Orsola-Malpighi, Bologna, Italy;

4. Department of Oncology, Unit of Lymphoid Malignancies, San Raffaele Scientific Institute, Milan, Italy;

5. Hematology, Azienda Ospedaliera Città della Salute e della Scienza, Turin, Italy;

6. Hematology, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria, Italy;

7. Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;

8. Hematology, Ospedale Businco, Cagliari, Italy;

9. Hematology, Policlinico Careggi, Florence, Italy;

10. Department of Hematology, Niguarda Ca' Granda Hospital, Milan, Italy;

11. Hematology Unit, Department of Oncology, Azienda Ospedaliera ASMN IRCCS Reggio Emilia, Italy;

12. Medical Oncology Unit, Ospedale di Circolo Fondazione Macchi, Varese, Italy;

13. Department of Hematology, Azienda Ospedaliera Papardo, Messina, Italy;

14. Onco-Hematology Department, Modena University, Modena, Italy; and

15. Cancer Research UK Centre, University of Southampton, Southampton, United Kingdom

Abstract

Key Points 18FDG PET/CT is a very important staging tool for patients with PMBCL. Metabolic activity defined by TLG on the baseline PET scan is a powerful predictor of PMBCL outcome.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/126/8/950/1391337/950.pdf

Reference46 articles.

1. Primary mediastinal B-cell lymphoma.;Boleti;Hematol Oncol,2007

2. The molecular pathogenesis of primary mediastinal large B-cell lymphoma.;Steidl;Blood,2011

3. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.;Savage;Blood,2003

4. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.;Rosenwald;J Exp Med,2003

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of the total lesion glycolysis (TLG) in predicting response of follicular lymphoma to rituximab;British Journal of Haematology;2024-08-27

2. Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphoma;Scientific Reports;2024-04-05

3. ПЭТ-КТ при гематологических злокачественных опухолях: что достигнуто и к чему стремиться;Clinical Oncohematology;2024-04-01

4. Semi-supervised learning towards automated segmentation of PET images with limited annotations: application to lymphoma patients;Physical and Engineering Sciences in Medicine;2024-03-21

5. Evaluating Outcome Prediction via Baseline, End-of-Treatment, and Delta Radiomics on PET-CT Images of Primary Mediastinal Large B-Cell Lymphoma;Cancers;2024-03-08